Positive results of a cost effectiveness study presented at the XXXIst International Workshop on Helicobacter & Microbiota in Inflammation and Cancer on September 14, 2018 in Kaunas (Lithuania). Data show that in patients with uninvestigated dyspepsia, the “Test and Treat” strategy incorporating Urea Breath Test as implemented in Spain is as effective and more cost effective than the Endoscopy-only strategy with regard to dyspepsia relief and gastric cancer prevention.
Arab Health 2018
During 4 days, International & Business Team managed our booth at Arab Health, the largest gathering of healthcare/Pharma in the MEA region. The 2018 edition included more than 4,200 exhibiting companies and more than 10,000 attendees from 150+ countries (mainly from MEA region). Our partner in Emirates & Saudi Arabia, Gulf Drug, was gold sponsor of the event, and we received very good feedback of their expertise in the Region.
Mayoly booth was based on French Pavillon even if our neighbour were from Belgium ! Was highlighted the Topicrem products, the HP Franchise with 1 KIBION DYNAMIC & 1 HELIPROBE, the IBS family and the Probiotics franchise, in addition to all others products of the Mayoly.
Supporting for a part the Contract Manufacturing activities (and Calcidose received a very good feedback !), the main objective was to (1) to find new products, and (2) to find new partners for new countries.
After around 200 business cards exchanges, and 4 exhausting days, the conclusion is very positive. We met a lot of Pharmaceutical companies & distributors from Emirates, Saudi Arabia, Iran, Irak, Syria, Jordan, Kuwait, Oman, Bahrain, Yemen, for Middle East, or Kenya and Sudan for Africa for example.
Products presentation, company introduction have been done already, and the follow-up of this event is now crucial, to be able to valuate these 4 days, by new business openings. Our key products have been plebiscited, but some others products, not targeted as priority, may have some potential based on the number of interests received (Colchicine, Calcidose, Cholurso, and the suppository range).
We hope now that business cases arriving in the coming months will be approved to increase our business level in this part of the world, where market growth is very interesting.
We already took an appointment for next year!